Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
05/2005
05/11/2005CN1201010C Mass production method of antimicrobial peptide and DNA construct and expression system thereof
05/11/2005CN1201009C Histidine protein-phosphatase
05/11/2005CN1201008C Yeast strains with interrupted ATF2 gene and use
05/11/2005CN1200950C Immuno-conjugated compound as protein or nucleic acid trasnferring carrier
05/10/2005US6891084 For foods/proliferation of Bifidobacterium/drugs for organ preservation solutions; genetic engineering
05/10/2005US6891083 For herbicides/marker systems; genetic engineering; cloning
05/10/2005US6891081 Transgenic mice over-expressing amyloid-beta alcohol dehydrogenase (ABAD) in brain as model of alzheimer's disease and uses thereof
05/10/2005US6890910 Murd protein and gene of Pseudomonas aeruginosa
05/10/2005US6890908 Modified ribozymes
05/10/2005US6890752 Synthases
05/10/2005US6890748 Production of lysosomal enzymes in plants by transient expression
05/10/2005US6890747 Phosphoinositide 3-kinases
05/10/2005US6890746 Gene participating in the production of homo-glutamic acid and utilization thereof
05/10/2005US6890745 For drug screening enzyme inhibitors/detecting/modulating caspase activity/apoptosis
05/10/2005US6890743 Geminin and Orc3N inhibit replication of herpesviruses, papillomaviruses, and polyomaviruses
05/10/2005US6890739 Use of uridine diphosphate glucose 4-epimerase
05/10/2005US6890732 Nucleic acid molecules which code for enzymes derived from wheat and which are involved in the synthesis of starch
05/10/2005US6890721 For treating Alzheimer's/Parkinson's disease/rheumatoid arthritis/sepsis/stroke/inflammation/ischemia/cardiovascular/ liver disease/multiple sclerosis/acquired immune deficiency syndrome(AIDS)/male pattern baldness/tumors/cancer
05/10/2005US6890572 Bacillus culture product; baked goods
05/10/2005US6890554 Genetic immunization with cationic lipids
05/10/2005US6890539 Peptide encoded by gene identified herein as pho2-2, obtainable from Group B Streptococcus, or a homologue or a functional fragment thereof; neonatal infections, urinary tract infections
05/10/2005US6890516 Identifying a substance capable of affecting long term memory in an animal comprising the determination that said substance alters activator homodimer, activator-repressor heterodimer and/ or repressor homodimer formation from normal
05/10/2005CA2118518C Over expression of single-stranded molecules
05/10/2005CA1341482C Process for preparing fragments of aids-associated retroviruses
05/06/2005WO2005040795A2 Diagnostics and therapeutics for diseases associated with aminopeptidase-like 1 (npepli)
05/06/2005WO2005040428A2 Detection of mutations in a gene associated with resistance to viral infection, oas1
05/06/2005WO2005040389A2 Compositions with chitinase activity
05/06/2005WO2005040381A1 Rice and products thereof having starch with an increased proportion of amylose
05/06/2005WO2005040372A1 Protease with improved stability in detergents
05/06/2005WO2005040371A1 Engineered enzymes and their use for synthesis of thioglycosides
05/06/2005WO2005040370A2 Thermostable hydrolase
05/06/2005WO2005040369A1 Process for producing penicillin
05/06/2005WO2005040368A2 Crystals of an aurora-a tpx2 complex, tpx2 binding site of aurora-a, aurora-a ligands and their use
05/06/2005WO2005040367A1 Vitamin k epoxide recycling polypeptide vkorc1, a therapeutic target of coumarin and their derivatives
05/06/2005WO2005040366A1 Trans-2-enoyl-coa reductase gene of euglena gracilis
05/06/2005WO2005040363A1 Glucosyltransferases
05/06/2005WO2005040344A2 Generation of stabilized proteins by combinatorial consensus mutagenesis
05/06/2005WO2005040334A2 Selective lipases and methods of screening therefor
05/06/2005WO2005040207A1 Tyrosine phosphorylation of cdk inhibitor proteins of the cip/kip family
05/06/2005WO2005040197A1 Compositions, methods and kits for biarsenical fluorophore labeling
05/06/2005WO2005040194A2 Methods and compositions for pdgf-c activation and inhibition
05/06/2005WO2005039615A1 Use of caspase-8 inhibitors for modulating hematopoiesis
05/06/2005WO2005039281A1 Genetically modified organisms and uses thereof
05/06/2005WO2005028636A8 Novel cbh1 homologs and variant cbh1 cellulases
05/06/2005WO2005017161A3 Chimeric peptides for the regulation of gtpases
05/06/2005WO2005017116A3 Thermostable peroxide-driven cytochrome p450 oxygenase variants and methods of use
05/06/2005WO2005000888A3 NOVEL β-ACTIN AND RPS21 PROMOTERS AND USES THEREOF
05/06/2005WO2004113561A3 Methods for diagnosing, monitoring, staging and treating heart failure
05/06/2005WO2004112482A8 Biological active coating components, coatings, and coated surfaces
05/06/2005WO2004111245A3 Gdc-2 genes conferring herbicide resistance
05/06/2005WO2004106508A3 Bioreactor containing cells expressing glycosyltransferase nucleic acids
05/06/2005WO2004099381A3 Genetically modified yeast species and fermentation processes using genetically modified yeast
05/06/2005WO2004098377A3 Methods and compositions for diagnosis and therapy of parkin-associated disorders
05/06/2005WO2004037979A3 Improved sso7-polymerase conjugate proteins
05/06/2005WO2004015096A8 Leech extracts for stents
05/06/2005WO2003010286A3 Nucleic acids, polypeptides, and methods for modulating apoptosis
05/06/2005WO2002072787A3 Telomerase expression repressor proteins and methods of using the same
05/06/2005CA2543789A1 Detection of mutations in a gene associated with resistance to viral infection, oas1
05/06/2005CA2543565A1 Use of caspase-8 inhibitors for modulating hematopoiesis
05/06/2005CA2543404A1 Novel inhibitor of the formation of advanced glycation end product and aldose reductase inhibitor
05/06/2005CA2542017A1 Vitamin k epoxide recycling polypeptide vkorc1, a therapeutic target of coumarin and their derivatives
05/06/2005CA2541141A1 Trans-2-enoyl-coa reductase gene of euglena gracilis
05/06/2005CA2540810A1 Crystals of an aurora-a tpx2 complex, tpx2 binding site of aurora-a, aurora-a ligands and their use
05/05/2005US20050097636 OAR polynucleotides, polypeptides and their use in PHA production in plants
05/05/2005US20050097634 Methods of increasing polypeptide accumulation in plants
05/05/2005US20050097632 Phenotype modifying genetic sequences
05/05/2005US20050096273 Regulation of matrix metalloproteinases by PSP94 family members
05/05/2005US20050096256 Compositions for manipulating the lifespan and stress response of cells and organisms
05/05/2005US20050096255 Methods of modulating activity of DXR
05/05/2005US20050095691 Muant acid phosphatase/phytase for use in enhancement nutrient quality and digestibility of animal feeds
05/05/2005US20050095689 Plant protein for use in enhancing ability to absorb insoluble iron in soils and for improving resistance to iron deficiency in plants
05/05/2005US20050095688 Process for the preparation of L-amino acids using strains of the family Enterobacteriaceae
05/05/2005US20050095683 Bacillus serine proteases for use as active agent in cleaning compounds and detergents
05/05/2005US20050095680 Using modified escherichia comprising enhanced carbamoyl-phosphate synthetase activity as a bioreactor for fermentation of arginine for use in medicines, animal feed and cosmetics
05/05/2005US20050095670 Low-substrate-specific racemase for use in producing racemates of various amino acids
05/05/2005US20050095669 Eubacterial rna-polymerase mutants with altered product production
05/05/2005US20050095668 Sepsis shock therapy; anticoagulants; antiinflammatory agents; exhibits an increased resistance towards inactivation by alpha-1-antitrypsin
05/05/2005US20050095625 Membrane-associated guanylate kinase peptides for use in identifying modulators for treatment and prevention of inflammation, cancer, arteriosclerosis and psoriasis
05/05/2005US20050095619 Enhanced heat resistant glucose dehydrogenase for coupling to oxido- or reductase enzymes to produce synthetic organic chemicals or precursors
05/05/2005US20050095615 Methods and compositions for detecting promoter activity and expressing fusion proteins
05/05/2005US20050095315 Process for the production of alcoholic beverages using maltseed
05/05/2005US20050095248 Use of inhibitor of cathepsin S based upon peptide sequence which comprises at least about 2-20 consecutive residues from preferred invariant chain cleavage site of cathepsin S, spanning from residue 68 to residue 90 of specified sequence
05/04/2005EP1528102A2 Cloning and recombinant productions of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon
05/04/2005EP1527191A1 Method for the biotransformation of carotenoids by means of a cytochrome p450 monooxygnase
05/04/2005EP1527189A2 Mutant proteinase inhibitors and uses thereof
05/04/2005EP1527183A2 Novel selection method
05/04/2005EP1527182A2 Process for the production of unsaturated fatty acids
05/04/2005EP1527181A1 Staphylococcal nuclease fusion proteins for the production of recombinant peptides
05/04/2005EP1527170A2 Crystal structure of beta-site app-cleaving enzyme (bace) mutants and uses thereof
05/04/2005EP1527169A2 Leech extracts for stents
05/04/2005EP1527168A1 Saccharose-6-phosphate phosphatase as a target for herbicides
05/04/2005EP1527167A2 Undecaprenyl pyrophosphate synthase (upps) enzyme and methods of use
05/04/2005EP1527166A1 Process for the preparation of l-3,4-dihydroxyphenylalanine by aerobic fermentation of a microorganism
05/04/2005EP1527165A2 A rhodococcus gene encoding aldoxime dehydratase
05/04/2005EP1527164A2 Cloning and sequencing of pyruvate decarboxylase (pdc) genes from bacteria and uses therefor
05/04/2005EP1527160A2 Production of glycosylated macrolides in e. coli
05/04/2005EP1527102A1 Proteins and methods useful for assessing risk of cardiovascular disease
05/04/2005EP1506312A4 Metalloprotease peptide substrates and methods
05/04/2005EP1364212A4 Three hybrid assay system
05/04/2005EP1362062B1 Concatameric immunoadhesion